Sargramostim Use in COVID-19 to Recover Patient Health

NCT04707664 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

600

Enrollment

INDUSTRY

Sponsor class

Conditions

Covid19
SARS-CoV Infection

Interventions

DRUG: Sargramostim
DRUG: Placebo

Sponsor

Partner Therapeutics, Inc.

Collaborators

[object Object]